nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—thyroid cancer—hypothyroidism	0.717	1	CtDrD
Vandetanib—ALB—Levothyroxine—hypothyroidism	0.028	0.304	CbGbCtD
Vandetanib—ALB—Liothyronine—hypothyroidism	0.028	0.304	CbGbCtD
Vandetanib—ALB—Liotrix—hypothyroidism	0.0273	0.297	CbGbCtD
Vandetanib—CYP3A4—Levothyroxine—hypothyroidism	0.00878	0.0953	CbGbCtD
Vandetanib—Cardio-respiratory arrest—Liothyronine—hypothyroidism	0.00615	0.117	CcSEcCtD
Vandetanib—Cardio-respiratory arrest—Liotrix—hypothyroidism	0.00222	0.0423	CcSEcCtD
Vandetanib—Intestinal perforation—Liotrix—hypothyroidism	0.00201	0.0382	CcSEcCtD
Vandetanib—Arrhythmia—Liothyronine—hypothyroidism	0.000985	0.0188	CcSEcCtD
Vandetanib—Cellulitis—Liotrix—hypothyroidism	0.000872	0.0166	CcSEcCtD
Vandetanib—Hypocalcaemia—Liotrix—hypothyroidism	0.000866	0.0165	CcSEcCtD
Vandetanib—Creatinine increased—Liotrix—hypothyroidism	0.000833	0.0159	CcSEcCtD
Vandetanib—Hypertension—Liothyronine—hypothyroidism	0.000829	0.0158	CcSEcCtD
Vandetanib—Hypoglycaemia—Levothyroxine—hypothyroidism	0.000802	0.0153	CcSEcCtD
Vandetanib—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.000802	0.0153	CcSEcCtD
Vandetanib—Cardiac failure—Dextrothyroxine—hypothyroidism	0.000802	0.0153	CcSEcCtD
Vandetanib—Cardiac failure—Levothyroxine—hypothyroidism	0.000802	0.0153	CcSEcCtD
Vandetanib—Cardiac arrest—Levothyroxine—hypothyroidism	0.000744	0.0142	CcSEcCtD
Vandetanib—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.000744	0.0142	CcSEcCtD
Vandetanib—Dehydration—Levothyroxine—hypothyroidism	0.000728	0.0139	CcSEcCtD
Vandetanib—Dehydration—Dextrothyroxine—hypothyroidism	0.000728	0.0139	CcSEcCtD
Vandetanib—Sepsis—Liotrix—hypothyroidism	0.000688	0.0131	CcSEcCtD
Vandetanib—Dysphagia—Levothyroxine—hypothyroidism	0.000676	0.0129	CcSEcCtD
Vandetanib—Dysphagia—Dextrothyroxine—hypothyroidism	0.000676	0.0129	CcSEcCtD
Vandetanib—Body temperature increased—Liothyronine—hypothyroidism	0.000619	0.0118	CcSEcCtD
Vandetanib—Weight decreased—Dextrothyroxine—hypothyroidism	0.000612	0.0117	CcSEcCtD
Vandetanib—Weight decreased—Levothyroxine—hypothyroidism	0.000612	0.0117	CcSEcCtD
Vandetanib—Hypoglycaemia—Liotrix—hypothyroidism	0.00059	0.0112	CcSEcCtD
Vandetanib—Cardiac failure—Liotrix—hypothyroidism	0.00059	0.0112	CcSEcCtD
Vandetanib—Cardiac arrest—Liotrix—hypothyroidism	0.000547	0.0104	CcSEcCtD
Vandetanib—Blood creatinine increased—Liotrix—hypothyroidism	0.000539	0.0103	CcSEcCtD
Vandetanib—Dehydration—Liotrix—hypothyroidism	0.000535	0.0102	CcSEcCtD
Vandetanib—Hypokalaemia—Liotrix—hypothyroidism	0.000524	0.00999	CcSEcCtD
Vandetanib—Dysphagia—Liotrix—hypothyroidism	0.000498	0.00948	CcSEcCtD
Vandetanib—Bronchospasm—Liotrix—hypothyroidism	0.000489	0.00933	CcSEcCtD
Vandetanib—Arrhythmia—Levothyroxine—hypothyroidism	0.000484	0.00922	CcSEcCtD
Vandetanib—Arrhythmia—Dextrothyroxine—hypothyroidism	0.000484	0.00922	CcSEcCtD
Vandetanib—Bronchitis—Liotrix—hypothyroidism	0.000479	0.00912	CcSEcCtD
Vandetanib—Alopecia—Dextrothyroxine—hypothyroidism	0.000478	0.00912	CcSEcCtD
Vandetanib—Alopecia—Levothyroxine—hypothyroidism	0.000478	0.00912	CcSEcCtD
Vandetanib—Weight decreased—Liotrix—hypothyroidism	0.00045	0.00858	CcSEcCtD
Vandetanib—Tremor—Dextrothyroxine—hypothyroidism	0.000442	0.00842	CcSEcCtD
Vandetanib—Tremor—Levothyroxine—hypothyroidism	0.000442	0.00842	CcSEcCtD
Vandetanib—Renal failure—Liotrix—hypothyroidism	0.000436	0.00831	CcSEcCtD
Vandetanib—Convulsion—Dextrothyroxine—hypothyroidism	0.000408	0.00778	CcSEcCtD
Vandetanib—Convulsion—Levothyroxine—hypothyroidism	0.000408	0.00778	CcSEcCtD
Vandetanib—Arthralgia—Levothyroxine—hypothyroidism	0.000401	0.00765	CcSEcCtD
Vandetanib—Arthralgia—Dextrothyroxine—hypothyroidism	0.000401	0.00765	CcSEcCtD
Vandetanib—Anxiety—Levothyroxine—hypothyroidism	0.0004	0.00762	CcSEcCtD
Vandetanib—Anxiety—Dextrothyroxine—hypothyroidism	0.0004	0.00762	CcSEcCtD
Vandetanib—Arrhythmia—Liotrix—hypothyroidism	0.000356	0.00678	CcSEcCtD
Vandetanib—Alopecia—Liotrix—hypothyroidism	0.000352	0.00671	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00035	0.00668	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00035	0.00668	CcSEcCtD
Vandetanib—Insomnia—Levothyroxine—hypothyroidism	0.000348	0.00663	CcSEcCtD
Vandetanib—Insomnia—Dextrothyroxine—hypothyroidism	0.000348	0.00663	CcSEcCtD
Vandetanib—Dyspnoea—Levothyroxine—hypothyroidism	0.000343	0.00654	CcSEcCtD
Vandetanib—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000343	0.00654	CcSEcCtD
Vandetanib—Dysgeusia—Liotrix—hypothyroidism	0.00034	0.00647	CcSEcCtD
Vandetanib—Fatigue—Dextrothyroxine—hypothyroidism	0.000332	0.00632	CcSEcCtD
Vandetanib—Fatigue—Levothyroxine—hypothyroidism	0.000332	0.00632	CcSEcCtD
Vandetanib—Vision blurred—Liotrix—hypothyroidism	0.000327	0.00623	CcSEcCtD
Vandetanib—Tremor—Liotrix—hypothyroidism	0.000325	0.00619	CcSEcCtD
Vandetanib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000315	0.006	CcSEcCtD
Vandetanib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000315	0.006	CcSEcCtD
Vandetanib—BMPR1B—testis—hypothyroidism	0.000305	0.00368	CbGeAlD
Vandetanib—MAP3K19—testis—hypothyroidism	0.000305	0.00368	CbGeAlD
Vandetanib—Loss of consciousness—Liotrix—hypothyroidism	0.000305	0.00581	CcSEcCtD
Vandetanib—Body temperature increased—Levothyroxine—hypothyroidism	0.000304	0.0058	CcSEcCtD
Vandetanib—Abdominal pain—Levothyroxine—hypothyroidism	0.000304	0.0058	CcSEcCtD
Vandetanib—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000304	0.0058	CcSEcCtD
Vandetanib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000304	0.0058	CcSEcCtD
Vandetanib—STK35—thyroid gland—hypothyroidism	0.000303	0.00365	CbGeAlD
Vandetanib—FYN—cardiovascular system—hypothyroidism	0.000303	0.00365	CbGeAlD
Vandetanib—Convulsion—Liotrix—hypothyroidism	0.0003	0.00573	CcSEcCtD
Vandetanib—EPHB6—heart—hypothyroidism	0.000299	0.00361	CbGeAlD
Vandetanib—Hypertension—Liotrix—hypothyroidism	0.000299	0.00571	CcSEcCtD
Vandetanib—YES1—adrenal cortex—hypothyroidism	0.000299	0.00361	CbGeAlD
Vandetanib—FLT3—female gonad—hypothyroidism	0.000299	0.0036	CbGeAlD
Vandetanib—EGFR—adrenal gland—hypothyroidism	0.000298	0.00359	CbGeAlD
Vandetanib—MKNK1—gonad—hypothyroidism	0.000298	0.00359	CbGeAlD
Vandetanib—TEK—cardiovascular system—hypothyroidism	0.000296	0.00356	CbGeAlD
Vandetanib—Chest pain—Liotrix—hypothyroidism	0.000295	0.00563	CcSEcCtD
Vandetanib—Arthralgia—Liotrix—hypothyroidism	0.000295	0.00563	CcSEcCtD
Vandetanib—ABL2—thyroid gland—hypothyroidism	0.000295	0.00355	CbGeAlD
Vandetanib—Anxiety—Liotrix—hypothyroidism	0.000294	0.00561	CcSEcCtD
Vandetanib—AXL—gonad—hypothyroidism	0.000293	0.00353	CbGeAlD
Vandetanib—LYN—liver—hypothyroidism	0.000293	0.00353	CbGeAlD
Vandetanib—STK35—female gonad—hypothyroidism	0.000292	0.00352	CbGeAlD
Vandetanib—MKNK1—pituitary gland—hypothyroidism	0.000291	0.00351	CbGeAlD
Vandetanib—FLT4—adrenal gland—hypothyroidism	0.000291	0.0035	CbGeAlD
Vandetanib—FLT4—blood—hypothyroidism	0.000291	0.0035	CbGeAlD
Vandetanib—YES1—heart—hypothyroidism	0.000289	0.00349	CbGeAlD
Vandetanib—RIPK2—adrenal gland—hypothyroidism	0.000289	0.00348	CbGeAlD
Vandetanib—RIPK2—blood—hypothyroidism	0.000289	0.00348	CbGeAlD
Vandetanib—VEGFA—adrenal gland—hypothyroidism	0.000288	0.00348	CbGeAlD
Vandetanib—EGFR—thyroid gland—hypothyroidism	0.000288	0.00347	CbGeAlD
Vandetanib—TYRO3—cerebellum—hypothyroidism	0.000288	0.00347	CbGeAlD
Vandetanib—EPHA5—cerebellum—hypothyroidism	0.000288	0.00347	CbGeAlD
Vandetanib—FGR—pituitary gland—hypothyroidism	0.000287	0.00346	CbGeAlD
Vandetanib—RET—pituitary gland—hypothyroidism	0.000287	0.00346	CbGeAlD
Vandetanib—FMO1—adrenal gland—hypothyroidism	0.000287	0.00346	CbGeAlD
Vandetanib—STK10—heart—hypothyroidism	0.000287	0.00346	CbGeAlD
Vandetanib—AXL—pituitary gland—hypothyroidism	0.000286	0.00345	CbGeAlD
Vandetanib—ABL2—female gonad—hypothyroidism	0.000285	0.00343	CbGeAlD
Vandetanib—Oedema—Liotrix—hypothyroidism	0.000283	0.00539	CcSEcCtD
Vandetanib—IRAK4—adrenal gland—hypothyroidism	0.000282	0.0034	CbGeAlD
Vandetanib—IRAK4—blood—hypothyroidism	0.000282	0.0034	CbGeAlD
Vandetanib—BMPR1B—cerebellum—hypothyroidism	0.000282	0.00339	CbGeAlD
Vandetanib—Infection—Liotrix—hypothyroidism	0.000281	0.00536	CcSEcCtD
Vandetanib—FLT4—thyroid gland—hypothyroidism	0.000281	0.00338	CbGeAlD
Vandetanib—RIPK2—thyroid gland—hypothyroidism	0.000279	0.00336	CbGeAlD
Vandetanib—SRC—heart—hypothyroidism	0.000278	0.00335	CbGeAlD
Vandetanib—VEGFA—thyroid gland—hypothyroidism	0.000278	0.00335	CbGeAlD
Vandetanib—EGFR—female gonad—hypothyroidism	0.000278	0.00335	CbGeAlD
Vandetanib—FMO3—pituitary gland—hypothyroidism	0.000278	0.00334	CbGeAlD
Vandetanib—FMO1—thyroid gland—hypothyroidism	0.000277	0.00334	CbGeAlD
Vandetanib—Asthenia—Dextrothyroxine—hypothyroidism	0.000276	0.00526	CcSEcCtD
Vandetanib—Asthenia—Levothyroxine—hypothyroidism	0.000276	0.00526	CcSEcCtD
Vandetanib—SLK—pituitary gland—hypothyroidism	0.000276	0.00332	CbGeAlD
Vandetanib—IRAK4—thyroid gland—hypothyroidism	0.000273	0.00328	CbGeAlD
Vandetanib—Pruritus—Dextrothyroxine—hypothyroidism	0.000272	0.00519	CcSEcCtD
Vandetanib—Pruritus—Levothyroxine—hypothyroidism	0.000272	0.00519	CcSEcCtD
Vandetanib—FLT4—female gonad—hypothyroidism	0.000271	0.00327	CbGeAlD
Vandetanib—STK10—cardiovascular system—hypothyroidism	0.000271	0.00326	CbGeAlD
Vandetanib—RIPK2—female gonad—hypothyroidism	0.00027	0.00325	CbGeAlD
Vandetanib—VEGFA—female gonad—hypothyroidism	0.000269	0.00324	CbGeAlD
Vandetanib—MAP4K5—gonad—hypothyroidism	0.000268	0.00323	CbGeAlD
Vandetanib—FYN—pituitary gland—hypothyroidism	0.000268	0.00323	CbGeAlD
Vandetanib—FMO1—female gonad—hypothyroidism	0.000267	0.00322	CbGeAlD
Vandetanib—ERBB3—thyroid gland—hypothyroidism	0.000267	0.00322	CbGeAlD
Vandetanib—KDR—adrenal cortex—hypothyroidism	0.000265	0.00319	CbGeAlD
Vandetanib—MAP2K5—adrenal cortex—hypothyroidism	0.000265	0.00319	CbGeAlD
Vandetanib—FLT3—testis—hypothyroidism	0.000265	0.00319	CbGeAlD
Vandetanib—IRAK4—female gonad—hypothyroidism	0.000263	0.00317	CbGeAlD
Vandetanib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000263	0.00502	CcSEcCtD
Vandetanib—Diarrhoea—Levothyroxine—hypothyroidism	0.000263	0.00502	CcSEcCtD
Vandetanib—SRC—cardiovascular system—hypothyroidism	0.000263	0.00316	CbGeAlD
Vandetanib—TEK—pituitary gland—hypothyroidism	0.000262	0.00315	CbGeAlD
Vandetanib—MAP4K5—pituitary gland—hypothyroidism	0.000262	0.00315	CbGeAlD
Vandetanib—MKNK1—adrenal gland—hypothyroidism	0.00026	0.00313	CbGeAlD
Vandetanib—MKNK1—blood—hypothyroidism	0.00026	0.00313	CbGeAlD
Vandetanib—STK35—testis—hypothyroidism	0.000259	0.00313	CbGeAlD
Vandetanib—ERBB3—female gonad—hypothyroidism	0.000258	0.00311	CbGeAlD
Vandetanib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000258	0.00491	CcSEcCtD
Vandetanib—FGR—adrenal gland—hypothyroidism	0.000257	0.00309	CbGeAlD
Vandetanib—RET—adrenal gland—hypothyroidism	0.000257	0.00309	CbGeAlD
Vandetanib—LCK—adrenal gland—hypothyroidism	0.000257	0.00309	CbGeAlD
Vandetanib—LCK—blood—hypothyroidism	0.000257	0.00309	CbGeAlD
Vandetanib—FGR—blood—hypothyroidism	0.000257	0.00309	CbGeAlD
Vandetanib—RET—blood—hypothyroidism	0.000257	0.00309	CbGeAlD
Vandetanib—MAP2K5—heart—hypothyroidism	0.000256	0.00309	CbGeAlD
Vandetanib—KDR—heart—hypothyroidism	0.000256	0.00309	CbGeAlD
Vandetanib—Insomnia—Liotrix—hypothyroidism	0.000256	0.00488	CcSEcCtD
Vandetanib—AXL—adrenal gland—hypothyroidism	0.000256	0.00308	CbGeAlD
Vandetanib—Paraesthesia—Liotrix—hypothyroidism	0.000254	0.00484	CcSEcCtD
Vandetanib—ABL2—testis—hypothyroidism	0.000253	0.00305	CbGeAlD
Vandetanib—Dyspnoea—Liotrix—hypothyroidism	0.000252	0.00481	CcSEcCtD
Vandetanib—MKNK1—thyroid gland—hypothyroidism	0.000251	0.00302	CbGeAlD
Vandetanib—FLT3—liver—hypothyroidism	0.00025	0.00302	CbGeAlD
Vandetanib—EPHB6—pituitary gland—hypothyroidism	0.00025	0.00301	CbGeAlD
Vandetanib—FMO3—adrenal gland—hypothyroidism	0.000248	0.00299	CbGeAlD
Vandetanib—YES1—gonad—hypothyroidism	0.000248	0.00299	CbGeAlD
Vandetanib—LCK—thyroid gland—hypothyroidism	0.000248	0.00298	CbGeAlD
Vandetanib—RET—thyroid gland—hypothyroidism	0.000248	0.00298	CbGeAlD
Vandetanib—FGR—thyroid gland—hypothyroidism	0.000248	0.00298	CbGeAlD
Vandetanib—AXL—thyroid gland—hypothyroidism	0.000247	0.00297	CbGeAlD
Vandetanib—EGFR—testis—hypothyroidism	0.000247	0.00297	CbGeAlD
Vandetanib—SLK—adrenal gland—hypothyroidism	0.000246	0.00297	CbGeAlD
Vandetanib—SLK—blood—hypothyroidism	0.000246	0.00296	CbGeAlD
Vandetanib—Decreased appetite—Liotrix—hypothyroidism	0.000246	0.00469	CcSEcCtD
Vandetanib—STK10—gonad—hypothyroidism	0.000246	0.00296	CbGeAlD
Vandetanib—STK35—liver—hypothyroidism	0.000245	0.00295	CbGeAlD
Vandetanib—Vomiting—Levothyroxine—hypothyroidism	0.000245	0.00466	CcSEcCtD
Vandetanib—Vomiting—Dextrothyroxine—hypothyroidism	0.000245	0.00466	CcSEcCtD
Vandetanib—FLT3—cerebellum—hypothyroidism	0.000245	0.00295	CbGeAlD
Vandetanib—Fatigue—Liotrix—hypothyroidism	0.000244	0.00465	CcSEcCtD
Vandetanib—Rash—Dextrothyroxine—hypothyroidism	0.000243	0.00462	CcSEcCtD
Vandetanib—Rash—Levothyroxine—hypothyroidism	0.000243	0.00462	CcSEcCtD
Vandetanib—MKNK1—female gonad—hypothyroidism	0.000242	0.00292	CbGeAlD
Vandetanib—Dermatitis—Dextrothyroxine—hypothyroidism	0.000242	0.00462	CcSEcCtD
Vandetanib—Dermatitis—Levothyroxine—hypothyroidism	0.000242	0.00462	CcSEcCtD
Vandetanib—Constipation—Liotrix—hypothyroidism	0.000242	0.00461	CcSEcCtD
Vandetanib—YES1—pituitary gland—hypothyroidism	0.000242	0.00291	CbGeAlD
Vandetanib—KDR—cardiovascular system—hypothyroidism	0.000242	0.00291	CbGeAlD
Vandetanib—MAP2K5—cardiovascular system—hypothyroidism	0.000242	0.00291	CbGeAlD
Vandetanib—Headache—Dextrothyroxine—hypothyroidism	0.000241	0.00459	CcSEcCtD
Vandetanib—Headache—Levothyroxine—hypothyroidism	0.000241	0.00459	CcSEcCtD
Vandetanib—FLT4—testis—hypothyroidism	0.00024	0.0029	CbGeAlD
Vandetanib—STK35—cerebellum—hypothyroidism	0.00024	0.00289	CbGeAlD
Vandetanib—LCK—female gonad—hypothyroidism	0.000239	0.00288	CbGeAlD
Vandetanib—FGR—female gonad—hypothyroidism	0.000239	0.00288	CbGeAlD
Vandetanib—FYN—adrenal gland—hypothyroidism	0.000239	0.00288	CbGeAlD
Vandetanib—FYN—blood—hypothyroidism	0.000239	0.00288	CbGeAlD
Vandetanib—FMO3—thyroid gland—hypothyroidism	0.000239	0.00288	CbGeAlD
Vandetanib—RIPK2—testis—hypothyroidism	0.000239	0.00288	CbGeAlD
Vandetanib—ABL2—liver—hypothyroidism	0.000239	0.00288	CbGeAlD
Vandetanib—VEGFA—testis—hypothyroidism	0.000239	0.00287	CbGeAlD
Vandetanib—AXL—female gonad—hypothyroidism	0.000238	0.00287	CbGeAlD
Vandetanib—SRC—gonad—hypothyroidism	0.000238	0.00287	CbGeAlD
Vandetanib—SLK—thyroid gland—hypothyroidism	0.000238	0.00286	CbGeAlD
Vandetanib—MAP4K5—adrenal gland—hypothyroidism	0.000234	0.00282	CbGeAlD
Vandetanib—TEK—adrenal gland—hypothyroidism	0.000234	0.00282	CbGeAlD
Vandetanib—MAP4K5—blood—hypothyroidism	0.000234	0.00282	CbGeAlD
Vandetanib—TEK—blood—hypothyroidism	0.000234	0.00282	CbGeAlD
Vandetanib—IRAK4—testis—hypothyroidism	0.000234	0.00281	CbGeAlD
Vandetanib—ABL2—cerebellum—hypothyroidism	0.000233	0.00281	CbGeAlD
Vandetanib—EGFR—liver—hypothyroidism	0.000233	0.00281	CbGeAlD
Vandetanib—Gastrointestinal pain—Liotrix—hypothyroidism	0.000231	0.00441	CcSEcCtD
Vandetanib—FYN—thyroid gland—hypothyroidism	0.000231	0.00278	CbGeAlD
Vandetanib—SLK—female gonad—hypothyroidism	0.000229	0.00277	CbGeAlD
Vandetanib—PDGFRB—adrenal cortex—hypothyroidism	0.000229	0.00276	CbGeAlD
Vandetanib—ERBB3—testis—hypothyroidism	0.000229	0.00276	CbGeAlD
Vandetanib—Nausea—Levothyroxine—hypothyroidism	0.000228	0.00436	CcSEcCtD
Vandetanib—Nausea—Dextrothyroxine—hypothyroidism	0.000228	0.00436	CcSEcCtD
Vandetanib—EGFR—cerebellum—hypothyroidism	0.000228	0.00275	CbGeAlD
Vandetanib—FLT4—liver—hypothyroidism	0.000227	0.00274	CbGeAlD
Vandetanib—RIPK2—liver—hypothyroidism	0.000226	0.00272	CbGeAlD
Vandetanib—MAP4K5—thyroid gland—hypothyroidism	0.000226	0.00272	CbGeAlD
Vandetanib—TEK—thyroid gland—hypothyroidism	0.000226	0.00272	CbGeAlD
Vandetanib—VEGFA—liver—hypothyroidism	0.000225	0.00272	CbGeAlD
Vandetanib—FMO1—liver—hypothyroidism	0.000224	0.0027	CbGeAlD
Vandetanib—Body temperature increased—Liotrix—hypothyroidism	0.000224	0.00426	CcSEcCtD
Vandetanib—Abdominal pain—Liotrix—hypothyroidism	0.000224	0.00426	CcSEcCtD
Vandetanib—EPHB6—adrenal gland—hypothyroidism	0.000223	0.00269	CbGeAlD
Vandetanib—EPHB6—blood—hypothyroidism	0.000223	0.00269	CbGeAlD
Vandetanib—FYN—female gonad—hypothyroidism	0.000223	0.00269	CbGeAlD
Vandetanib—PDGFRB—heart—hypothyroidism	0.000222	0.00267	CbGeAlD
Vandetanib—RIPK2—cerebellum—hypothyroidism	0.000221	0.00266	CbGeAlD
Vandetanib—IRAK4—liver—hypothyroidism	0.000221	0.00266	CbGeAlD
Vandetanib—VEGFA—cerebellum—hypothyroidism	0.00022	0.00265	CbGeAlD
Vandetanib—TEK—female gonad—hypothyroidism	0.000218	0.00263	CbGeAlD
Vandetanib—MAP4K5—female gonad—hypothyroidism	0.000218	0.00263	CbGeAlD
Vandetanib—ERBB3—liver—hypothyroidism	0.000216	0.00261	CbGeAlD
Vandetanib—YES1—adrenal gland—hypothyroidism	0.000216	0.0026	CbGeAlD
Vandetanib—YES1—blood—hypothyroidism	0.000216	0.0026	CbGeAlD
Vandetanib—IRAK4—cerebellum—hypothyroidism	0.000216	0.0026	CbGeAlD
Vandetanib—EPHB6—thyroid gland—hypothyroidism	0.000216	0.0026	CbGeAlD
Vandetanib—MKNK1—testis—hypothyroidism	0.000215	0.00259	CbGeAlD
Vandetanib—STK10—adrenal gland—hypothyroidism	0.000214	0.00258	CbGeAlD
Vandetanib—STK10—blood—hypothyroidism	0.000214	0.00258	CbGeAlD
Vandetanib—KDR—pituitary gland—hypothyroidism	0.000214	0.00258	CbGeAlD
Vandetanib—MAP2K5—pituitary gland—hypothyroidism	0.000214	0.00258	CbGeAlD
Vandetanib—FGR—testis—hypothyroidism	0.000212	0.00256	CbGeAlD
Vandetanib—RET—testis—hypothyroidism	0.000212	0.00256	CbGeAlD
Vandetanib—LCK—testis—hypothyroidism	0.000212	0.00256	CbGeAlD
Vandetanib—AXL—testis—hypothyroidism	0.000211	0.00255	CbGeAlD
Vandetanib—ERBB3—cerebellum—hypothyroidism	0.000211	0.00255	CbGeAlD
Vandetanib—PDGFRB—cardiovascular system—hypothyroidism	0.000209	0.00252	CbGeAlD
Vandetanib—YES1—thyroid gland—hypothyroidism	0.000208	0.00251	CbGeAlD
Vandetanib—EPHB6—female gonad—hypothyroidism	0.000208	0.00251	CbGeAlD
Vandetanib—SRC—adrenal gland—hypothyroidism	0.000208	0.0025	CbGeAlD
Vandetanib—SRC—blood—hypothyroidism	0.000208	0.0025	CbGeAlD
Vandetanib—STK10—thyroid gland—hypothyroidism	0.000207	0.00249	CbGeAlD
Vandetanib—FMO3—testis—hypothyroidism	0.000205	0.00247	CbGeAlD
Vandetanib—ABL1—adrenal cortex—hypothyroidism	0.000204	0.00246	CbGeAlD
Vandetanib—SLK—testis—hypothyroidism	0.000204	0.00245	CbGeAlD
Vandetanib—MKNK1—liver—hypothyroidism	0.000203	0.00245	CbGeAlD
Vandetanib—Asthenia—Liotrix—hypothyroidism	0.000203	0.00387	CcSEcCtD
Vandetanib—YES1—female gonad—hypothyroidism	0.000201	0.00243	CbGeAlD
Vandetanib—LCK—liver—hypothyroidism	0.000201	0.00242	CbGeAlD
Vandetanib—FGR—liver—hypothyroidism	0.000201	0.00242	CbGeAlD
Vandetanib—SRC—thyroid gland—hypothyroidism	0.0002	0.00242	CbGeAlD
Vandetanib—Pruritus—Liotrix—hypothyroidism	0.0002	0.00382	CcSEcCtD
Vandetanib—AXL—liver—hypothyroidism	0.0002	0.00241	CbGeAlD
Vandetanib—STK10—female gonad—hypothyroidism	0.0002	0.0024	CbGeAlD
Vandetanib—MKNK1—cerebellum—hypothyroidism	0.000199	0.00239	CbGeAlD
Vandetanib—FYN—testis—hypothyroidism	0.000198	0.00238	CbGeAlD
Vandetanib—ABL1—heart—hypothyroidism	0.000198	0.00238	CbGeAlD
Vandetanib—RET—cerebellum—hypothyroidism	0.000196	0.00236	CbGeAlD
Vandetanib—AXL—cerebellum—hypothyroidism	0.000195	0.00235	CbGeAlD
Vandetanib—FMO3—liver—hypothyroidism	0.000194	0.00234	CbGeAlD
Vandetanib—SRC—female gonad—hypothyroidism	0.000194	0.00233	CbGeAlD
Vandetanib—Diarrhoea—Liotrix—hypothyroidism	0.000194	0.00369	CcSEcCtD
Vandetanib—TEK—testis—hypothyroidism	0.000193	0.00233	CbGeAlD
Vandetanib—MAP4K5—testis—hypothyroidism	0.000193	0.00233	CbGeAlD
Vandetanib—SLK—liver—hypothyroidism	0.000192	0.00232	CbGeAlD
Vandetanib—KDR—adrenal gland—hypothyroidism	0.000191	0.0023	CbGeAlD
Vandetanib—MAP2K5—adrenal gland—hypothyroidism	0.000191	0.0023	CbGeAlD
Vandetanib—KDR—blood—hypothyroidism	0.000191	0.0023	CbGeAlD
Vandetanib—MAP2K5—blood—hypothyroidism	0.000191	0.0023	CbGeAlD
Vandetanib—PDGFRB—gonad—hypothyroidism	0.00019	0.00229	CbGeAlD
Vandetanib—SLK—cerebellum—hypothyroidism	0.000188	0.00227	CbGeAlD
Vandetanib—Dizziness—Liotrix—hypothyroidism	0.000187	0.00357	CcSEcCtD
Vandetanib—FYN—liver—hypothyroidism	0.000187	0.00225	CbGeAlD
Vandetanib—ABL1—cardiovascular system—hypothyroidism	0.000186	0.00225	CbGeAlD
Vandetanib—PDGFRB—pituitary gland—hypothyroidism	0.000185	0.00223	CbGeAlD
Vandetanib—EPHB6—testis—hypothyroidism	0.000185	0.00223	CbGeAlD
Vandetanib—MAP2K5—thyroid gland—hypothyroidism	0.000184	0.00222	CbGeAlD
Vandetanib—KDR—thyroid gland—hypothyroidism	0.000184	0.00222	CbGeAlD
Vandetanib—MAP4K5—liver—hypothyroidism	0.000183	0.0022	CbGeAlD
Vandetanib—TEK—liver—hypothyroidism	0.000183	0.0022	CbGeAlD
Vandetanib—FYN—cerebellum—hypothyroidism	0.000183	0.0022	CbGeAlD
Vandetanib—ALB—heart—hypothyroidism	0.000182	0.0022	CbGeAlD
Vandetanib—Vomiting—Liotrix—hypothyroidism	0.00018	0.00343	CcSEcCtD
Vandetanib—TEK—cerebellum—hypothyroidism	0.000179	0.00215	CbGeAlD
Vandetanib—MAP4K5—cerebellum—hypothyroidism	0.000179	0.00215	CbGeAlD
Vandetanib—YES1—testis—hypothyroidism	0.000179	0.00215	CbGeAlD
Vandetanib—Rash—Liotrix—hypothyroidism	0.000178	0.0034	CcSEcCtD
Vandetanib—Dermatitis—Liotrix—hypothyroidism	0.000178	0.0034	CcSEcCtD
Vandetanib—MAP2K5—female gonad—hypothyroidism	0.000178	0.00215	CbGeAlD
Vandetanib—KDR—female gonad—hypothyroidism	0.000178	0.00215	CbGeAlD
Vandetanib—Headache—Liotrix—hypothyroidism	0.000177	0.00338	CcSEcCtD
Vandetanib—STK10—testis—hypothyroidism	0.000177	0.00213	CbGeAlD
Vandetanib—SRC—testis—hypothyroidism	0.000172	0.00207	CbGeAlD
Vandetanib—EPHB6—cerebellum—hypothyroidism	0.000171	0.00206	CbGeAlD
Vandetanib—ABL1—gonad—hypothyroidism	0.000169	0.00204	CbGeAlD
Vandetanib—YES1—liver—hypothyroidism	0.000169	0.00203	CbGeAlD
Vandetanib—Nausea—Liotrix—hypothyroidism	0.000168	0.0032	CcSEcCtD
Vandetanib—STK10—liver—hypothyroidism	0.000167	0.00202	CbGeAlD
Vandetanib—PDGFRB—adrenal gland—hypothyroidism	0.000165	0.00199	CbGeAlD
Vandetanib—PDGFRB—blood—hypothyroidism	0.000165	0.00199	CbGeAlD
Vandetanib—ABL1—pituitary gland—hypothyroidism	0.000165	0.00199	CbGeAlD
Vandetanib—YES1—cerebellum—hypothyroidism	0.000165	0.00199	CbGeAlD
Vandetanib—STK10—cerebellum—hypothyroidism	0.000163	0.00197	CbGeAlD
Vandetanib—SRC—liver—hypothyroidism	0.000162	0.00196	CbGeAlD
Vandetanib—PDGFRB—thyroid gland—hypothyroidism	0.00016	0.00192	CbGeAlD
Vandetanib—SRC—cerebellum—hypothyroidism	0.000159	0.00191	CbGeAlD
Vandetanib—MAP2K5—testis—hypothyroidism	0.000158	0.0019	CbGeAlD
Vandetanib—KDR—testis—hypothyroidism	0.000158	0.0019	CbGeAlD
Vandetanib—ABCC1—adrenal cortex—hypothyroidism	0.000156	0.00187	CbGeAlD
Vandetanib—ORM1—blood—hypothyroidism	0.000155	0.00187	CbGeAlD
Vandetanib—PDGFRB—female gonad—hypothyroidism	0.000154	0.00186	CbGeAlD
Vandetanib—ABCC1—heart—hypothyroidism	0.00015	0.00181	CbGeAlD
Vandetanib—KDR—liver—hypothyroidism	0.000149	0.0018	CbGeAlD
Vandetanib—MAP2K5—liver—hypothyroidism	0.000149	0.0018	CbGeAlD
Vandetanib—ABL1—adrenal gland—hypothyroidism	0.000147	0.00178	CbGeAlD
Vandetanib—ABL1—blood—hypothyroidism	0.000147	0.00178	CbGeAlD
Vandetanib—MAP2K5—cerebellum—hypothyroidism	0.000146	0.00176	CbGeAlD
Vandetanib—KDR—cerebellum—hypothyroidism	0.000146	0.00176	CbGeAlD
Vandetanib—ABL1—thyroid gland—hypothyroidism	0.000142	0.00171	CbGeAlD
Vandetanib—ABL1—female gonad—hypothyroidism	0.000137	0.00166	CbGeAlD
Vandetanib—PDGFRB—testis—hypothyroidism	0.000137	0.00165	CbGeAlD
Vandetanib—ALB—adrenal gland—hypothyroidism	0.000136	0.00164	CbGeAlD
Vandetanib—PDGFRB—liver—hypothyroidism	0.000129	0.00156	CbGeAlD
Vandetanib—ABCG2—adrenal cortex—hypothyroidism	0.000129	0.00155	CbGeAlD
Vandetanib—PDGFRB—cerebellum—hypothyroidism	0.000126	0.00152	CbGeAlD
Vandetanib—ABCC1—pituitary gland—hypothyroidism	0.000126	0.00151	CbGeAlD
Vandetanib—ABCG2—heart—hypothyroidism	0.000125	0.0015	CbGeAlD
Vandetanib—ABL1—testis—hypothyroidism	0.000122	0.00147	CbGeAlD
Vandetanib—ORM1—liver—hypothyroidism	0.000121	0.00146	CbGeAlD
Vandetanib—ABL1—liver—hypothyroidism	0.000115	0.00139	CbGeAlD
Vandetanib—ABL1—cerebellum—hypothyroidism	0.000113	0.00136	CbGeAlD
Vandetanib—ALB—testis—hypothyroidism	0.000113	0.00136	CbGeAlD
Vandetanib—ABCC1—adrenal gland—hypothyroidism	0.000112	0.00135	CbGeAlD
Vandetanib—ABCC1—blood—hypothyroidism	0.000112	0.00135	CbGeAlD
Vandetanib—ABCC1—thyroid gland—hypothyroidism	0.000108	0.00131	CbGeAlD
Vandetanib—ALB—liver—hypothyroidism	0.000106	0.00128	CbGeAlD
Vandetanib—ABCC1—female gonad—hypothyroidism	0.000105	0.00126	CbGeAlD
Vandetanib—ABCG2—pituitary gland—hypothyroidism	0.000104	0.00125	CbGeAlD
Vandetanib—ABCG2—adrenal gland—hypothyroidism	9.3e-05	0.00112	CbGeAlD
Vandetanib—ABCG2—blood—hypothyroidism	9.3e-05	0.00112	CbGeAlD
Vandetanib—ABCC1—testis—hypothyroidism	9.29e-05	0.00112	CbGeAlD
Vandetanib—ABCG2—thyroid gland—hypothyroidism	8.97e-05	0.00108	CbGeAlD
Vandetanib—ABCC1—liver—hypothyroidism	8.78e-05	0.00106	CbGeAlD
Vandetanib—ABCG2—female gonad—hypothyroidism	8.67e-05	0.00104	CbGeAlD
Vandetanib—ABCC1—cerebellum—hypothyroidism	8.58e-05	0.00103	CbGeAlD
Vandetanib—ABCG2—testis—hypothyroidism	7.69e-05	0.000927	CbGeAlD
Vandetanib—ABCG2—liver—hypothyroidism	7.27e-05	0.000876	CbGeAlD
Vandetanib—ABCG2—cerebellum—hypothyroidism	7.1e-05	0.000856	CbGeAlD
Vandetanib—CYP3A4—blood—hypothyroidism	6.48e-05	0.00078	CbGeAlD
Vandetanib—CYP3A4—liver—hypothyroidism	5.06e-05	0.00061	CbGeAlD
Vandetanib—ABL1—Immune System—CLTC—hypothyroidism	2.34e-05	0.000428	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CLTC—hypothyroidism	2.33e-05	0.000425	CbGpPWpGaD
Vandetanib—FYN—Immune System—CLTC—hypothyroidism	2.32e-05	0.000423	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—PRL—hypothyroidism	2.3e-05	0.00042	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TRH—hypothyroidism	2.28e-05	0.000416	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.28e-05	0.000416	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—SH2B3—hypothyroidism	2.24e-05	0.000409	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—VAV3—hypothyroidism	2.23e-05	0.000408	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—VAV3—hypothyroidism	2.19e-05	0.000401	CbGpPWpGaD
Vandetanib—FGR—Hemostasis—IGF1—hypothyroidism	2.16e-05	0.000395	CbGpPWpGaD
Vandetanib—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	2.16e-05	0.000395	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—VAV3—hypothyroidism	2.16e-05	0.000394	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—AVP—hypothyroidism	2.15e-05	0.000393	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—VAV3—hypothyroidism	2.15e-05	0.000392	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—VAV3—hypothyroidism	2.13e-05	0.000388	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—VAV3—hypothyroidism	2.12e-05	0.000388	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—VAV3—hypothyroidism	2.12e-05	0.000387	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CLTC—hypothyroidism	2.11e-05	0.000386	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—VAV3—hypothyroidism	2.11e-05	0.000385	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TRH—hypothyroidism	2.09e-05	0.000381	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—VAV3—hypothyroidism	2.08e-05	0.000381	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—PRL—hypothyroidism	2.08e-05	0.00038	CbGpPWpGaD
Vandetanib—LCK—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	2.07e-05	0.000379	CbGpPWpGaD
Vandetanib—SRC—Focal Adhesion—IGF1—hypothyroidism	2.07e-05	0.000378	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	2.06e-05	0.000377	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CLTC—hypothyroidism	2.04e-05	0.000373	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—SLC5A5—hypothyroidism	2.04e-05	0.000373	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TSHB—hypothyroidism	2.03e-05	0.000371	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TSHR—hypothyroidism	2.03e-05	0.000371	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TRH—hypothyroidism	2.03e-05	0.000371	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.02e-05	0.000369	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	2.01e-05	0.000367	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TRH—hypothyroidism	2.01e-05	0.000367	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CLTC—hypothyroidism	2e-05	0.000366	CbGpPWpGaD
Vandetanib—BLK—Immune System—PRL—hypothyroidism	2e-05	0.000365	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—PRL—hypothyroidism	2e-05	0.000365	CbGpPWpGaD
Vandetanib—FGR—Immune System—PRL—hypothyroidism	1.99e-05	0.000364	CbGpPWpGaD
Vandetanib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	1.97e-05	0.00036	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—VAV3—hypothyroidism	1.95e-05	0.000355	CbGpPWpGaD
Vandetanib—LCK—Immune System—CLTC—hypothyroidism	1.93e-05	0.000353	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—VAV3—hypothyroidism	1.92e-05	0.000351	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—VAV3—hypothyroidism	1.9e-05	0.000348	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—VAV3—hypothyroidism	1.9e-05	0.000346	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—TRH—hypothyroidism	1.89e-05	0.000346	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—VAV3—hypothyroidism	1.88e-05	0.000343	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TSHR—hypothyroidism	1.86e-05	0.00034	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TSHB—hypothyroidism	1.86e-05	0.00034	CbGpPWpGaD
Vandetanib—ALB—Metabolism—IYD—hypothyroidism	1.86e-05	0.000339	CbGpPWpGaD
Vandetanib—BLK—Immune System—VAV3—hypothyroidism	1.85e-05	0.000338	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—VAV3—hypothyroidism	1.85e-05	0.000338	CbGpPWpGaD
Vandetanib—FGR—Immune System—VAV3—hypothyroidism	1.84e-05	0.000337	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—VAV3—hypothyroidism	1.83e-05	0.000335	CbGpPWpGaD
Vandetanib—SRC—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	1.83e-05	0.000335	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—PRL—hypothyroidism	1.83e-05	0.000335	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TRH—hypothyroidism	1.83e-05	0.000334	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TSHB—hypothyroidism	1.81e-05	0.000331	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—SH2B3—hypothyroidism	1.81e-05	0.000331	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TSHR—hypothyroidism	1.81e-05	0.000331	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—IGF1—hypothyroidism	1.81e-05	0.00033	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TSHB—hypothyroidism	1.79e-05	0.000327	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TSHR—hypothyroidism	1.79e-05	0.000327	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—AVP—hypothyroidism	1.78e-05	0.000326	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.78e-05	0.000325	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TRH—hypothyroidism	1.76e-05	0.000322	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—IGF1—hypothyroidism	1.75e-05	0.000319	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—VAV3—hypothyroidism	1.73e-05	0.000317	CbGpPWpGaD
Vandetanib—SRC—Immune System—CLTC—hypothyroidism	1.71e-05	0.000312	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—POMC—hypothyroidism	1.71e-05	0.000312	CbGpPWpGaD
Vandetanib—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	1.7e-05	0.000311	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—VAV3—hypothyroidism	1.69e-05	0.00031	CbGpPWpGaD
Vandetanib—ERBB3—Disease—PRL—hypothyroidism	1.69e-05	0.000309	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—TSHB—hypothyroidism	1.69e-05	0.000308	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—TSHR—hypothyroidism	1.69e-05	0.000308	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—SH2B3—hypothyroidism	1.66e-05	0.000303	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—IGF1—hypothyroidism	1.64e-05	0.0003	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TSHR—hypothyroidism	1.63e-05	0.000297	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TSHB—hypothyroidism	1.63e-05	0.000297	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—VAV3—hypothyroidism	1.62e-05	0.000296	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—SH2B3—hypothyroidism	1.61e-05	0.000295	CbGpPWpGaD
Vandetanib—YES1—Immune System—PRL—hypothyroidism	1.61e-05	0.000294	CbGpPWpGaD
Vandetanib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	1.6e-05	0.000292	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—SH2B3—hypothyroidism	1.6e-05	0.000292	CbGpPWpGaD
Vandetanib—ABCC1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.59e-05	0.000291	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ATP5O—hypothyroidism	1.58e-05	0.000288	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TSHB—hypothyroidism	1.57e-05	0.000287	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TSHR—hypothyroidism	1.57e-05	0.000287	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—VAV3—hypothyroidism	1.56e-05	0.000286	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—POMC—hypothyroidism	1.56e-05	0.000285	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—VAV3—hypothyroidism	1.56e-05	0.000285	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CLTC—hypothyroidism	1.55e-05	0.000284	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—VAV3—hypothyroidism	1.54e-05	0.00028	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CLTC—hypothyroidism	1.52e-05	0.000278	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—SH2B3—hypothyroidism	1.51e-05	0.000276	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—IGF1—hypothyroidism	1.5e-05	0.000275	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CLTC—hypothyroidism	1.5e-05	0.000274	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—POMC—hypothyroidism	1.49e-05	0.000273	CbGpPWpGaD
Vandetanib—YES1—Immune System—VAV3—hypothyroidism	1.49e-05	0.000272	CbGpPWpGaD
Vandetanib—ALB—Metabolism—TPO—hypothyroidism	1.48e-05	0.000271	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—SH2B3—hypothyroidism	1.45e-05	0.000265	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—POMC—hypothyroidism	1.43e-05	0.000261	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—SH2B3—hypothyroidism	1.4e-05	0.000256	CbGpPWpGaD
Vandetanib—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	1.4e-05	0.000256	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—VAV3—hypothyroidism	1.38e-05	0.000253	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.38e-05	0.000251	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—IGF1—hypothyroidism	1.37e-05	0.000251	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TRH—hypothyroidism	1.34e-05	0.000245	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—PRL—hypothyroidism	1.34e-05	0.000245	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TRH—hypothyroidism	1.32e-05	0.00024	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—IGF1—hypothyroidism	1.3e-05	0.000238	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—IGF1—hypothyroidism	1.3e-05	0.000237	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TRH—hypothyroidism	1.3e-05	0.000237	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CLTC—hypothyroidism	1.29e-05	0.000237	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—IGF1—hypothyroidism	1.28e-05	0.000234	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—TSHB—hypothyroidism	1.27e-05	0.000231	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CLTC—hypothyroidism	1.25e-05	0.000228	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—VAV3—hypothyroidism	1.24e-05	0.000227	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	1.24e-05	0.000226	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—PRL—hypothyroidism	1.23e-05	0.000225	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PRL—hypothyroidism	1.22e-05	0.000224	CbGpPWpGaD
Vandetanib—LYN—Immune System—PRL—hypothyroidism	1.2e-05	0.000219	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PRL—hypothyroidism	1.2e-05	0.000219	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—AVP—hypothyroidism	1.2e-05	0.000219	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TSHB—hypothyroidism	1.2e-05	0.000219	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TSHR—hypothyroidism	1.2e-05	0.000219	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PRL—hypothyroidism	1.19e-05	0.000218	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PRL—hypothyroidism	1.18e-05	0.000216	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—POMC—hypothyroidism	1.18e-05	0.000216	CbGpPWpGaD
Vandetanib—FYN—Immune System—PRL—hypothyroidism	1.18e-05	0.000216	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TSHB—hypothyroidism	1.17e-05	0.000214	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TSHR—hypothyroidism	1.17e-05	0.000214	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TSHB—hypothyroidism	1.15e-05	0.000211	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TSHR—hypothyroidism	1.15e-05	0.000211	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—IGF1—hypothyroidism	1.14e-05	0.000208	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—VAV3—hypothyroidism	1.14e-05	0.000208	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—VAV3—hypothyroidism	1.13e-05	0.000207	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PRL—hypothyroidism	1.13e-05	0.000207	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PIK3C2A—hypothyroidism	1.13e-05	0.000206	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TRH—hypothyroidism	1.12e-05	0.000204	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—TSHB—hypothyroidism	1.11e-05	0.000203	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.11e-05	0.000203	CbGpPWpGaD
Vandetanib—LYN—Immune System—VAV3—hypothyroidism	1.11e-05	0.000203	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—VAV3—hypothyroidism	1.11e-05	0.000202	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CLTC—hypothyroidism	1.1e-05	0.000202	CbGpPWpGaD
Vandetanib—ABL1—Immune System—VAV3—hypothyroidism	1.1e-05	0.000202	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.1e-05	0.000201	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—VAV3—hypothyroidism	1.1e-05	0.0002	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—AVP—hypothyroidism	1.1e-05	0.0002	CbGpPWpGaD
Vandetanib—FYN—Immune System—VAV3—hypothyroidism	1.09e-05	0.0002	CbGpPWpGaD
Vandetanib—FYN—Disease—PRL—hypothyroidism	1.09e-05	0.000199	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TRH—hypothyroidism	1.08e-05	0.000197	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PRL—hypothyroidism	1.08e-05	0.000197	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—IGF1—hypothyroidism	1.07e-05	0.000195	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—POMC—hypothyroidism	1.07e-05	0.000195	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SH2B3—hypothyroidism	1.07e-05	0.000195	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—AVP—hypothyroidism	1.07e-05	0.000195	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—AVP—hypothyroidism	1.06e-05	0.000193	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SH2B3—hypothyroidism	1.05e-05	0.000191	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PRL—hypothyroidism	1.04e-05	0.00019	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—VAV3—hypothyroidism	1.04e-05	0.000189	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—VAV3—hypothyroidism	1.03e-05	0.000189	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SH2B3—hypothyroidism	1.03e-05	0.000188	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PRL—hypothyroidism	1.02e-05	0.000186	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—IYD—hypothyroidism	1e-05	0.000183	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PRL—hypothyroidism	9.99e-06	0.000183	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TSHB—hypothyroidism	9.97e-06	0.000182	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TSHR—hypothyroidism	9.97e-06	0.000182	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—VAV3—hypothyroidism	9.96e-06	0.000182	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—AVP—hypothyroidism	9.95e-06	0.000182	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PIK3C2A—hypothyroidism	9.92e-06	0.000181	CbGpPWpGaD
Vandetanib—LCK—Immune System—PRL—hypothyroidism	9.83e-06	0.00018	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—VAV3—hypothyroidism	9.62e-06	0.000176	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TSHB—hypothyroidism	9.61e-06	0.000176	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TSHR—hypothyroidism	9.61e-06	0.000176	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—AVP—hypothyroidism	9.59e-06	0.000175	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TRH—hypothyroidism	9.55e-06	0.000174	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—SLC5A5—hypothyroidism	9.47e-06	0.000173	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—IGF1—hypothyroidism	9.45e-06	0.000173	CbGpPWpGaD
Vandetanib—EGFR—Immune System—VAV3—hypothyroidism	9.44e-06	0.000172	CbGpPWpGaD
Vandetanib—EGFR—Disease—PRL—hypothyroidism	9.42e-06	0.000172	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—AVP—hypothyroidism	9.27e-06	0.000169	CbGpPWpGaD
Vandetanib—LCK—Immune System—VAV3—hypothyroidism	9.09e-06	0.000166	CbGpPWpGaD
Vandetanib—LCK—Disease—PRL—hypothyroidism	9.08e-06	0.000166	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SH2B3—hypothyroidism	8.89e-06	0.000162	CbGpPWpGaD
Vandetanib—SRC—Immune System—PRL—hypothyroidism	8.7e-06	0.000159	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	8.65e-06	0.000158	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SH2B3—hypothyroidism	8.57e-06	0.000156	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ATP5O—hypothyroidism	8.52e-06	0.000156	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TSHB—hypothyroidism	8.51e-06	0.000155	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TSHR—hypothyroidism	8.51e-06	0.000155	CbGpPWpGaD
Vandetanib—CYP3A4—Biological oxidations—POMC—hypothyroidism	8.49e-06	0.000155	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—SLC5A5—hypothyroidism	8.34e-06	0.000152	CbGpPWpGaD
Vandetanib—SRC—Immune System—VAV3—hypothyroidism	8.05e-06	0.000147	CbGpPWpGaD
Vandetanib—SRC—Disease—PRL—hypothyroidism	8.03e-06	0.000147	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TPO—hypothyroidism	8.01e-06	0.000146	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—POMC—hypothyroidism	7.96e-06	0.000145	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PRL—hypothyroidism	7.92e-06	0.000145	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PRL—hypothyroidism	7.75e-06	0.000142	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IGF1—hypothyroidism	7.66e-06	0.00014	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PRL—hypothyroidism	7.63e-06	0.000139	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SH2B3—hypothyroidism	7.58e-06	0.000139	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—VAV3—hypothyroidism	7.33e-06	0.000134	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—POMC—hypothyroidism	7.28e-06	0.000133	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—VAV3—hypothyroidism	7.17e-06	0.000131	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—POMC—hypothyroidism	7.09e-06	0.00013	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—VAV3—hypothyroidism	7.06e-06	0.000129	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—AVP—hypothyroidism	7.06e-06	0.000129	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—POMC—hypothyroidism	7.02e-06	0.000128	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IGF1—hypothyroidism	7e-06	0.000128	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—AVP—hypothyroidism	6.91e-06	0.000126	CbGpPWpGaD
Vandetanib—ALB—Metabolism—TSHB—hypothyroidism	6.87e-06	0.000126	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IGF1—hypothyroidism	6.82e-06	0.000125	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—AVP—hypothyroidism	6.8e-06	0.000124	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IGF1—hypothyroidism	6.75e-06	0.000123	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—POMC—hypothyroidism	6.61e-06	0.000121	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PRL—hypothyroidism	6.59e-06	0.00012	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IGF1—hypothyroidism	6.38e-06	0.000117	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—POMC—hypothyroidism	6.38e-06	0.000116	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PRL—hypothyroidism	6.36e-06	0.000116	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—POMC—hypothyroidism	6.16e-06	0.000113	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IGF1—hypothyroidism	6.13e-06	0.000112	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PIK3C2A—hypothyroidism	6.12e-06	0.000112	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—VAV3—hypothyroidism	6.1e-06	0.000111	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.04e-06	0.00011	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IGF1—hypothyroidism	5.92e-06	0.000108	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—VAV3—hypothyroidism	5.88e-06	0.000107	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—AVP—hypothyroidism	5.88e-06	0.000107	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—AVP—hypothyroidism	5.66e-06	0.000103	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PRL—hypothyroidism	5.63e-06	0.000103	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VAV3—hypothyroidism	5.2e-06	9.51e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—SLC5A5—hypothyroidism	5.14e-06	9.4e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AVP—hypothyroidism	5.01e-06	9.16e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—POMC—hypothyroidism	4.96e-06	9.05e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—POMC—hypothyroidism	4.69e-06	8.57e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—POMC—hypothyroidism	4.59e-06	8.39e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—POMC—hypothyroidism	4.52e-06	8.26e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IGF1—hypothyroidism	4.51e-06	8.24e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IGF1—hypothyroidism	4.42e-06	8.07e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—POMC—hypothyroidism	4.36e-06	7.97e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IGF1—hypothyroidism	4.35e-06	7.94e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—POMC—hypothyroidism	3.91e-06	7.14e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—POMC—hypothyroidism	3.76e-06	6.88e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IGF1—hypothyroidism	3.76e-06	6.86e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TSHB—hypothyroidism	3.71e-06	6.78e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IGF1—hypothyroidism	3.62e-06	6.61e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—POMC—hypothyroidism	3.33e-06	6.09e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	3.31e-06	6.04e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IGF1—hypothyroidism	3.21e-06	5.86e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.78e-06	5.07e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—POMC—hypothyroidism	2.69e-06	4.92e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—POMC—hypothyroidism	1.45e-06	2.65e-05	CbGpPWpGaD
